| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,401.00
|
|
Change (%)
|
73.85 (5.56%)
|
|
Best Buy (RS)
|
1401.15(x7)
|
|
Best Sell (RS)
|
1402.45(x248)
|
|
Today's Range (RS)
|
1,354.15
-
1,432.55
|
|
52-Week Range (RS)
|
1,165.55
-
1,672.20
|
|
Beta (1 Year)
|
0.55
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50 |
| News |
|
Corporate Details |
| Cipla appoints President & Global Chief – Integrated Product Development |
| Board of Cipla recommends final dividend |
| Cipla consolidated net profit declines 54.61% in the March 2026 quarter |
| Cipla Q4 profit declines 55% YoY |
| Cipla gains after USFDA nod for generic albuterol inhaler |
| Cipla Ltd spurts 4.25%, gains for third straight session |
| Cipla's manufacturing facility in Goa gets two observations in Form 483 from US FDA |
| Cipla's Goa unit completes USFDA inspection with two observations |
| Cipla consolidated net profit declines 56.97% in the December 2025 quarter |
| Cipla slides as Q3 PAT tanks 57% YoY to Rs 676 crore |
|
|
|
| Incoporation Year : 1935 |
| Chairman : Y K Hamied |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Cipla Ltd
Cipla House Peninsula Buss Par,
Ganpatrao Kadam Mg Lower Parel,
Mumbai,
Maharashtra-400013 |
Phone:91-22-24826000
Fax:91-22-24826120 |
| E-Mail : cosecretary@cipla.com, contactus@cipla.com |
| URL : http://www.cipla.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
06-May-2026 |
1365.25 |
-2.79 |
| 1Month |
13-Apr-2026 |
1211.30 |
9.56 |
| 3Month |
13-Feb-2026 |
1330.85 |
-0.28 |
| 6Month |
13-Nov-2025 |
1525.80 |
-13.02 |
| 1Year |
13-May-2025 |
1519.45 |
-12.66 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Flexi Cap Fund |
2.74 |
2750.16 |
| Parag Parikh Flexi Cap Fund |
1.33 |
1878.56 |
| SBI Nifty 50 ETF |
0.67 |
1393.54 |
| HDFC Focused Fund |
3.49 |
914.25 |
| ICICI Pru Value Fund |
1.34 |
798.69 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,844.05 |
1.08 |
1,885.65 |
1,547.25 |
437,734.67 |
| Dr Reddys Laboratories Ltd |
1,260.30 |
-0.38 |
1,377.95 |
1,149.00 |
105,592.45 |
| Lupin Ltd |
2,248.55 |
1.49 |
2,492.00 |
1,838.65 |
101,293.89 |
| Mankind Pharma Ltd |
2,441.85 |
1.43 |
2,726.75 |
1,909.90 |
99,384.29 |
| Zydus Lifesciences Ltd |
980.10 |
4.38 |
1,059.00 |
835.85 |
94,480.34 |
|
|
|
|